Cargando…

Outcomes of metastatic neuroendocrine carcinoma of the gallbladder

BACKGROUND: Neuroendocrine carcinoma of the gallbladder (NECGB) is a rare pathological entity. They are found to be aggressive cancers. Treatment strategies are based largely on extrapolation from other small cell cancers. Survival is poor compared to adenocarcinoma. Data from low- and middle-income...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Joydeep, Chatterjee, Meheli, Ganguly, Sandip, Dabkara, Deepak, Biswas, Bivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929769/ https://www.ncbi.nlm.nih.gov/pubmed/33680088 http://dx.doi.org/10.3332/ecancer.2021.1174

Ejemplares similares

PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
por: Ghosh, Joydeep, et al.
Publicado: (2021)

Metastatic Gastric cancer: Real world scenario from a developing country
por: Ganguly, Sandip, et al.
Publicado: (2018)

Outcome of testicular non-seminomatous germ cell tumours: report from a tertiary cancer centre in eastern India
por: Biswas, Bivas, et al.
Publicado: (2021)

Metachronous muscle metastasis in a case of metastatic gallbladder cancer with TP35 gene mutation: A rare case report
por: Ghosh, Joydeep, et al.
Publicado: (2019)

Multimodality treatment outcome in patients with primary malignant mediastinal germ cell tumor in adults
por: Biswas, Bivas, et al.
Publicado: (2020)

Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India
por: Roy, Somnath, et al.
Publicado: (2021)

Clinicopathological characteristics and treatment outcome in small cell lung cancer: A single institutional experience from India
por: Ganguly, Sandip, et al.
Publicado: (2020)

Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India
por: Ghosh, Joydeep, et al.
Publicado: (2020)

Early Experience with Dabrafenib–Trametinib Combination in Patients with BRAF-Mutated Malignant Melanoma—A Single-Center Experience
por: Ganguly, Sandip, et al.
Publicado: (2021)

Multidisciplinary management of ovarian germ cell tumours—a single institutional study from India
por: Ganguly, Sandip, et al.
Publicado: (2021)

Not so ‘rare’—an example of malignant melanoma in India: report from a tertiary cancer centre
por: Biswas, Bivas, et al.
Publicado: (2021)

Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India
por: Ganguly, Sandip, et al.
Publicado: (2022)

First-line Rucaparib Plus Bevacizumab Maintenance Completed One-Year in Germline BRCA1-Mutated Advanced Ovarian Cancer
por: Roy, Somnath, et al.
Publicado: (2022)

Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder
por: Jung, Jiyoon, et al.
Publicado: (2018)

Neuroendocrine Carcinoma of the Gallbladder
por: Vidal Panduro, Daniel A, et al.
Publicado: (2022)

Age‐specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Gallbladder infarction and liver abscess formation following right hepatic artery chemoembolization for metastatic neuroendocrine tumor
por: Sampson, Christopher, et al.
Publicado: (2010)

Metastatic gallbladder carcinoma presenting as an ovarian mass
por: Rehman, Nidhin, et al.
Publicado: (2021)

Gallbladder neuroendocrine carcinoma: An important differential diagnosis of gallbladder adenocarcinoma
por: Ikezawa, Kenji, et al.
Publicado: (2021)

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
por: Ahn, H K, et al.
Publicado: (2013)

Rare Case of Gallbladder Neuroendocrine Carcinoma
por: Rennie, Andrew T, et al.
Publicado: (2022)

Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects
por: Pushpam, Deepam, et al.
Publicado: (2020)

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
por: Formica, V, et al.
Publicado: (2007)

Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report
por: Skalický, Adam, et al.
Publicado: (2019)

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
por: Nwosu, A C, et al.
Publicado: (2008)

Update in clinical management for gallbladder neuroendocrine carcinoma
por: Chu, Hongwu, et al.
Publicado: (2021)

Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab
por: Kanda, Shinichiro, et al.
Publicado: (2023)

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
por: Hezel, A F, et al.
Publicado: (2014)

Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas
por: Olsen, Ingrid H., et al.
Publicado: (2012)

Laryngeal Neuroendocrine Carcinomas: A Retrospective Study of 14 Cases
por: Zhu, Yingying, et al.
Publicado: (2015)

Neuroendocrine Tumor of the Gallbladder
por: Monier, Ahmed, et al.
Publicado: (2015)

Neuroendocrine tumors of the gallbladder
por: Niu, Chunyuan, et al.
Publicado: (2020)

Metastatic large-cell neuroendocrine carcinoma of the lung masquerading as a primary gallbladder carcinoma: A case report
por: Syposs, Chauncey, et al.
Publicado: (2023)

Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
por: Liu, Fatao, et al.
Publicado: (2021)

Can surgical treatment be justified for neuroendocrine carcinoma of the gallbladder?
por: You, Yung Hun, et al.
Publicado: (2019)

Gallbladder neuroendocrine carcinoma: A single center experience
por: Chu, Hongwu, et al.
Publicado: (2020)

Gallbladder Neuroendocrine Carcinoma: A Rare Endocrine Tumor
por: Siddamreddy, Suman, et al.
Publicado: (2020)

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
por: El-Khoueiry, A B, et al.
Publicado: (2014)

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
por: Duran, I, et al.
Publicado: (2006)

The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas
por: Capretti, G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddkckeh8np01i789tjn40vctkf